LLNL, UC Davis Partner to Personalize Cancer Medications

News   Oct 29, 2014

 
LLNL, UC Davis Partner to Personalize Cancer Medications
 
 
 

RELATED ARTICLES

Antimalarial Drugs Could Offer Clinical Benefit to Cancer Patients

News

Antimalarial drugs chloroquine and hydroxychloroquine could find another use as cancer treatments, according to a new clinical study published in ecancermedicalscience.

READ MORE

Ocean Floor Mud Reveals Secrets of Past European Climate

News

Samples of sediment taken from the ocean floor of the North Atlantic Ocean have given researchers an unprecedented insight into the reasons why Europe’s climate has changed over the past 3000 years.

READ MORE

Pre-Diabetes Discovery Marks Step Towards Precision Medicine

News

Identification of three molecules that can be used to accurately assess pre-diabetes – a key predictor of conditions such as diabetes and high blood pressure – has brought precision medicine for humans a step closer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE